Nanfang Hospital, Southern Medical University: Neoplasms trials

The registry lists 12 Neoplasms studies with Nanfang Hospital, Southern Medical University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 3 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Correlation Analysis of Gene Characteristics of Malignant Tumors With PrognosisRecruitingNCT07622667
• Study of Peripheral Blood CHI3L1 to Predict Tumor Response to RadiotherapyNot yet recruitingNCT07071688
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCRecruitingNCT06177925Phase 2
• First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid TumorsNot yet recruitingNCT06134531Phase 1
• OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap MethodRecruitingNCT05450835Not applicable
• Safety and Efficacy of OGT Method Versus the Traditional Overlap MethodCompletedNCT05442502
• Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCTCompletedNCT05290545Phase 3
• Induced-T Cell Like NK Cells for B Cell MalignanciesStatus unknownNCT04747093Phase 1/2
• Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCTStatus unknownNCT03733340Phase 2/3
• The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLMStatus unknownNCT03686254Phase 2/3
• Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)Status unknownNCT03488446
• ESTD vs. VATS for Upper Gastrointestinal Submucosal TumorsStatus unknownNCT01768104Not applicable